Cornerstone Capital Management Holdings’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$1.11M	Buy	22,914 +1,900	+9%	+$96.1K	0.01%	876
2017 Q3	$1.14M	Sell	21,014 -2,500	-11%	-$147K	0.01%	904
2017 Q2	$1.32M	Sell	23,514 -1,216	-5%	-$48.7K	0.01%	842
2017 Q1	$968K	Buy	+24,730	New	+$788K	0.01%	937
2016 Q4	–	Sell	-2,110	Closed	-$47K	–	1457
2016 Q3	$47K	Sell	2,110 -1,100	-34%	-$25.8K	﹤0.01%	1292
2016 Q2	$76K	Sell	3,210 -300	-9%	-$7.41K	﹤0.01%	1289
2016 Q1	$72K	Sell	3,510 -3,500	-50%	-$111K	﹤0.01%	1359
2015 Q4	$361K	Buy	7,010 +2,810	+67%	+$136K	﹤0.01%	1101
2015 Q3	$179K	Buy	4,200 +400	+11%	+$19.3K	﹤0.01%	1238
2015 Q2	$173K	Buy	3,800 +500	+15%	+$20.1K	﹤0.01%	1219
2015 Q1	$125K	Sell	3,300 -2,600	-44%	-$89.3K	﹤0.01%	1241
2014 Q4	$167K	Buy	+5,900	New	+$164K	﹤0.01%	1113
2014 Q1	–	Sell	-2	Closed	–	–	1430
2013 Q4	$0	Sell	2 -27,698	-100%	-$673K	﹤0.01%	1354
2013 Q3	$741K	Buy	+27,700	New	+$659K	0.01%	881

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

Cornerstone Capital Management Holdings's PTLA Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its Portola Pharmaceuticals, Inc. (PTLA) stake by 9% in Q4 2017, buying an estimated $96.1K and bringing the position to 22,914 shares worth $1.11M. The position accounts for 0.01% of the portfolio, ranked #876.

Cornerstone Capital Management Holdings first reported a position in PTLA in Q3 2013 and has held it in 14 quarters since. The position peaked at $1.32M in Q2 2017. 215 funds tracked by Wall St. Rank hold PTLA as of Q4 2017.

Cornerstone Capital Management Holdings held 22,914 shares of Portola Pharmaceuticals, Inc. worth $1.11M as of Q4 2017.
Cornerstone Capital Management Holdings bought 1,900 Portola Pharmaceuticals, Inc. shares in Q4 2017, an estimated $96.1K.
Portola Pharmaceuticals, Inc. made up 0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #876 holding.
Cornerstone Capital Management Holdings first reported a position in Portola Pharmaceuticals, Inc. in Q3 2013 and has held it in 14 quarters since.
Cornerstone Capital Management Holdings's Portola Pharmaceuticals, Inc. position peaked at $1.32M in Q2 2017.
215 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.